Fillers & Facial Balancing
Chin Botox vs. Filler: Choosing for Smoothness, Shape, and Balance
Read the guide
Fillers & Facial Balancing

In this guide
Chin Botox and chin filler address different concerns. Botulinum toxin changes muscle activity; a chin filler adds soft-tissue volume. If you notice a pebbled surface when your chin tightens, that calls for a different discussion from wanting more forward projection in your side profile. Understanding the difference can help you explain your goal without choosing an injection before an assessment. Botox Cosmetic prescribing information, FDA chin-filler explanation.
This guide compares movement-related mentalis dimpling with chin projection. It provides questions to take to a qualified clinician, rather than a personal treatment recommendation.
The mentalis is a muscle in the chin that helps support and move the lower lip. Its contraction can produce chin bunching or an orange-peel appearance. The way it works matters alongside the underlying structure. Original anatomy study.
For a consultation, try describing your concern in ordinary language:
Bring photographs that show what you mean, including an ordinary resting expression. A photograph can start the conversation; it cannot establish which treatment suits you. Ask the clinician to explain their assessment before discussing a product.
Botox Cosmetic is the brand name for onabotulinumtoxinA. Its current U.S. labeling does not include mentalis dimpling, so this chin use is off-label. Its units cannot be compared with or converted into units of other botulinum toxin preparations. Current manufacturer label.
Off-label does not mean that FDA has assessed and approved that particular use. Ask what evidence supports the proposal and what uncertainty remains for your circumstances. FDA explanation of off-label use.
A small 2005 placebo-controlled study treated opposite halves of the chin differently. It found improvement in mentalis wrinkles, including during contraction. That limited study supports discussing a movement-related goal; it does not establish how every patient will respond or compare toxin directly with filler. Original chin-rhytid trial.
Chin filler is discussed when the goal involves adding volume and changing the chin profile. Approval depends on the exact product and use. For example, Restylane Defyne is a hyaluronic acid gel approved for chin augmentation to improve the profile in adults over 21 with mild to moderate chin retrusion. That example does not establish a clinic’s product stock or your candidacy. U.S. product instructions.
Ask which filler is proposed, why its chin indication fits the goal, and what the clinician would leave unchanged. A plan to add projection should explain the intended shape, rather than simply offer a fuller chin.
It should not be presented as a predictable substitute. A 2017 series studied 11 selected patients with a high-riding, hyperactive mentalis and an underprojected bony chin. Chin position changed vertically after onabotulinumtoxinA, but the average change in forward projection was not statistically significant; some chins became more projected and others less. Original photographic study.
That distinction helps frame the decision: an altered appearance after muscle relaxation does not promise added projection. If both dimpling and profile shape concern you, ask for a separate explanation of each. Neither concern automatically establishes a need for both treatments.
The mentalis helps support lower-lip function. Anatomy research highlights the importance of avoiding unwanted effects on that function. Ask about lower-lip weakness, mouth closure and changes in expression, including how a problem would be assessed. An anatomy study cannot supply your individual complication rate. Cadaveric and ultrasound study.
Discuss your health conditions, allergies, medicines and previous injections before treatment. Botox Cosmetic carries a boxed warning about toxin effects spreading beyond the injection site. Seek immediate medical attention for difficulty swallowing, speaking or breathing after treatment. Prescribing information and Medication Guide.
Filler commonly causes swelling, bruising or tenderness. Rare accidental injection into a blood vessel can cause tissue damage, blindness or stroke. Seek immediate medical attention for unusual pain, vision changes, white, gray or blue skin near the injection site, or stroke symptoms during or shortly after filler treatment. FDA filler safety guidance.
You do not need to arrive committed to either option. Leave with an explanation you understand and time to decide.
For local information, Calista’s chin filler service page describes its existing offering. Calista does not carry the Botox brand; this comparison does not announce mentalis treatment availability. Confirm the exact service and product directly. Current Calista product information.
Common questions
No. The appearance alone does not establish a treatment need. Discuss whether movement contributes to the dimpling and whether you actually want a change in projection. The clinician's assessment should connect the proposed option with your goal.
Mentalis dimpling is absent from the current Botox Cosmetic U.S. label. Ask the clinician to explain the proposed off-label use and its limits. Manufacturer prescribing information.
No. Ask what each proposed treatment would address, whether either is appropriate, and whether choosing no treatment fits your priorities. A comparison article cannot establish that you need a combined plan.